The series on “New Progress and Challenge in Gynecological Cancer” is edited by Dr. Danbo Wang from Liaoning Cancer Hospital and Institute, Shenyang, China.
Editorial
New progress and challenge in gynecological cancer
Original Article
Value of diffusion-weighted imaging in preoperative evaluation and prediction of postoperative supplementary therapy for patients with cervical cancer
Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study
Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study
Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer
Efficacy evaluation of vaginal-assisted laparoscopic radical hysterectomy and laparoscopic radical hysterectomy for cervical cancer: a single-center retrospective case series study
Establishment of a molecular risk model for the prognosis of cervical cancer based on microRNA expression
Systemic characterization of alternative splicing related to prognosis, immune infiltration, and drug sensitivity analysis in ovarian cancer
Management of stage I occult uterine leiomyosarcoma: effects of morcellation, second-look surgery, and adjuvant treatments on survival
Disclosure:
The special series “New Progress and Challenge in Gynecological Cancer” was commissioned by the editorial office, Annals of Translational Medicine without any funding or sponsorship. Danbo Wang served as the unpaid Guest Editor of the series and was not involved in the peer-review process or editorial decision for the papers published in this series. More details about the journal's peer review policy is available at: https://atm.amegroups.org/pages/view/peer-review-process.